Treatment: The treatment included a coronally advanced flap (CAF) because there was an amount, even if very small of remaining keratinized tissue (1 mm). The patient’s biotype was thin, and the affected root was buccally displaced. The rationale of using Emdogain® was to improve the quality of the attachment between the newly formed connective tissue and the root surface. By depositing the Amelogenins on the root, Emdogain® promotes the cells of the blood clot to be transformed in cementoblasts and fibroblasts, and this eventually improves the quality of new connective tissue attachment with respect to long junctional epithelium. Another reason why Emdogain® was used, was to improve the soft tissue healing and this is important when the patient has aesthetic requests, as the patient do not want to wait only for the long-term outcomes but short-term results as well. Furthermore, it was decided to add the use of mucoderm® because the objective was not to only achieve root coverage which can be achieved with CAF itself, but also to increase the soft tissue thickness, which is a condition that is a critical for the long-term maintenance of the outcome. In terms of post-operative course, it was optimal. The patient did not have any pain at all, she presented no swelling nor hematoma, and from the first follow-up visit there was a nice adaptation and blending of the treated area.